A forum for researchers, students and applicants in the field of cyclodextrin technology
The cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) pathway plays an important role in tumor development and formation of metastases. It was earlier
Although CD has been engineered into various nano-sized formulations, their main role was to incorporate a drug of interest for
International Conference on Alzheimer’s Disease & Dementia is scheduled Hilton Rome Airport ,Rome, Italy from July 20 – 22, 2020. This International Conference
Underdog Pharmaceuticals has launched with nearly $4 million in seed funding to develop treatments for atherosclerosis, a progressive condition in
“World Congress on Neuroscience and Brain Disorders” is scheduled to be held from March 30-31, 2020 in Osaka, Japan. The
Cyclo Therapeutics, Inc. formerly CTD Holdings, Inc., a biotechnology company that develops cyclodextrin-based products for the treatment of disease, announced
The annual National Niemann Pick Disease Family Conference will be held on August 15-18, 2019, in Bloomington, US. The conference
The effect of Methyl BCD (RAMEB) on cytoskeleton was studied. It was found that disassembling the actin network did not
Aldeyra Therapeutics Announced Results from the SOLACE Trial in Noninfectious Anterior Uveitis. The main points are: Statistical Significance Not Achieved
Lin et al. have recently reported on the mechanism of pain development and manipulation by methyl BCD [1]. A mouse
